Clinical Trial Update: Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for elesclomol sodium in patients with relapsed or refractory acute myeloid leukemia, sponsored by Synta Pharmaceuticals. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Elesclomol Sodium (elesclomol)

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: UNKNOWN